Stocks and Investing Stocks and Investing
Fri, January 31, 2014
Thu, January 30, 2014
Wed, January 29, 2014
Tue, January 28, 2014
Mon, January 27, 2014
Fri, January 24, 2014
Thu, January 23, 2014
Wed, January 22, 2014
Tue, January 21, 2014
Fri, January 17, 2014
Thu, January 16, 2014
Wed, January 15, 2014
Tue, January 14, 2014
Mon, January 13, 2014
Fri, January 10, 2014
Thu, January 9, 2014
Wed, January 8, 2014
Tue, January 7, 2014
Mon, January 6, 2014

Joel Beatty Downgraded (SRPT) to Strong Sell and Held Target at $13 on, Jan 6th, 2014


Published on 2024-10-25 03:57:49 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Citigroup, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Strong Sell and Held Target at $13 on, Jan 6th, 2014.

Joel has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Joel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Maintained at Hold with Decreased Target to $17 on, Tuesday, November 12th, 2013


This is the rating of the analyst that currently disagrees with Joel


  • Yun Zhong of "Janney Montgomery Scott" Downgraded from Hold to Strong Sell and Decreased Target to $10 on, Tuesday, November 12th, 2013
Similar Stocks and Investing Articles